Clinical Trial Update: Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 safety study of recombinant human hyaluronidase (Chemophase) with mitomycin in superficial bladder cancer has completed; results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Chemophase
• Mitomycin (Mitomycin)

Snippet

Sponsor: Halozyme Therapeutics | Conditions: Bladder Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-10-29